Dr. Johannes Fischer


  • PhD & MSc in Biochemistry and Medical Doctor
  • Joined Wellington in 2020 as Senior Associate, was promoted to Principal in 2022, and to Partner in 2023
  • Former Consultant and Project leader at the Life Sciences practice of L.E.K. Consulting
  • M&A support and corporate strategies for both analogue and digital assets

The future belongs to those who believe in the beauty of their dreams.

— Eleanor Roosevelt


Johannes joined Wellington Partners in 2020 as a Senior Associate in the Life Sciences team, he was promoted to Principal in 2022 and Partner in 2023.

Prior to joining Wellington Partners, Johannes was a Management Consultant at the Life Sciences practice of L.E.K. Consulting, where he managed and executed numerous projects for leading pharma, medical technology and laboratory supplies companies as well as private equity investors. With his team, Johannes provided M&A support, developed corporate strategies, assessed organizations to enhance their performance and explored product strategies for analogue and digital assets in multiple geographies.

Johannes holds an MSc in Biochemistry, a PhD in Biotechnology and a Medical Doctorate from Technical University Munich, Germany. As part of his PhD research at King Abdullah University of Science and Technology in Jeddah, Saudi-Arabia, Johannes explored the fundamentals of Artificial Metalloenzymes (ArMs) through means of protein crystallography and spectroscopy and developed a novel scaffold that acts as template for future ArMs research.

Johannes is a commercial advisor to a cosmetics start-up in Germany and to a food delivery service company in Saudi-Arabia, which he also co-founded.